–
Статьи в журналах
-
- 2017 Phase 2 placebo-controlled, double-blind trial of dasatinib added to gemcitabine for patients with locally-advanced pancreatic cancer
- Evans, (Evans T.R.J, Van Cutsem T.R.J.), (Van Cutsem E., Moore E.)., (Moore M.J., Bazin M.J.), (Bazin I.S., Rosemurgy I.S.), (Rosemurgy A., Bodoky A.)., (Bodoky G., Deplanque G.)., (Deplanque G., Harrison G.)., (Harrison M., Melichar M.)., (Melichar B., Pezet B.)., (Pezet D., ) D.
- в журнале Annals of Oncology, издательство Oxford University Press (United Kingdom), том 28, № 2, с. 354-361 DOI